CNTB vs VLTO · rev $64.0K vs P/E 29, rev $5.50B
Connect Biopharma Holdings Ltd (CNTB) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
CNTB currently screens at market cap $63.3M. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the CNTB and VLTO stock pages for the full models.
Not investment advice.